Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […] …read more […]
Wall Street’s main stock indexes were little changed on Tuesday, hovering near record highs, as investors awaited concrete news on whether U.S. tariffs on Chinese imports would take effect on Dec. 15, a potential turning point in the two countries’ trade dispute that has convulsed markets.
Federal Reserve Chair Jerome Powell has taken a glass-half-full view of the U.S. economy but the trouble may be that the glass has gotten smaller and has a few cracks.
Top officials from Canada, Mexico and the United States signed a fresh overhaul of their quarter-century-old regional trade pact on Tuesday that aims to improve enforcement of worker rights and hold down prices for biologic drugs by eliminating a patent provision.
Senate Majority Leader Mitch McConnell said on Tuesday the U.S. Senate would not take up the USMCA trade deal next week before congressional recess.
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] …read more […]
The drug stock is ripe for a short squeeze, too …read more […]
Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp’s drug to correct irregular rhythm in the upper chambers of the heart in adult patients. Brinavess, currently available in 41 countries including the European Union and Canada, aims to restore normal heart rhythm in patients experiencing erratic rhythm due to a condition known as atrial fibrillation, or AFib. …read more […]
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds’ top 3 stock picks returned 41.7% this year and beat […] …read more […]
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like… …read more […]
Peloton’s stock tumbled after Citron Research issued a 2020 price target of $5. Yahoo Finance’s Zack Guzman and Heidi Chung discuss with Payne Capital Management President Ryan Payne on YFi PM. …read more […]
(Bloomberg) — Peloton shares tumbled on Tuesday, dropping as much as 8.3% after Citron Research wrote that increasing competition and a high valuation could result in a massive sell-off in 2020.The firm sees “clear flaws in the Peloton business model” and wrote that the stock could fall to $5 next year. Based on the Monday close of $34.77, that target represents downside of more than 85%. At current levels, Peloton is up nearly 12% since its September initial public offering.Peloton’s current valuation is “unrealistic” and “disconnected from all reality,” the firm wrote in a report, adding that the fitness company …read more […]
Amazon.com Inc said on Tuesday it had issued a fix to rectify security flaws in certain of its Blink home camera systems after a cyber security firm found vulnerabilities that could let hackers hijack the device.
U.S. stocks gave up gains to trade nearly flat in a choppy session on Tuesday as investors focussed on trade-related headlines ahead of a new round of tariffs on Chinese goods.
U.S. senators grilled Apple Inc and Facebook Inc executives over their encryption practices on Tuesday and threatened to regulate the technology unless the companies make encrypted user data accessible to law enforcement.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
